Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Category list : Global health

Sort by: Newest first Oldest first A-Z Z-A

  • Zolpidem dose should be halved, says US regulator Subscription

    18 JAN 2013 13:40

    Recommended doses for zolpidem should be lowered because the drug can impair activities such as driving the day after use, the US Food and Drug Administration has recommended.

  • X-ray of spine

    Zoledronic acid studies highlight benefits in cancer

    20 AUG 2008 16:01

    Zoledronic acid prevents bone loss in premenopausal women undergoing chemotherapy for breast cancer, a new study confirms.

  • Zoledronic acid may reduce spread of cancer

    7 APR 2010 15:05

    Zoledronic acid, given as an adjuvant to chemotherapy, could decrease the spread of breast cancer in women with locally advanced disease, according to a phase II study published online in The Lancet (1 April 2010).

  • Ventilator pump

    Zanamivir should not be reformulated as liquid

    16 OCT 2009 9:20

    Zanamivir (Relenza) inhalation powder should not be reconstituted in any liquid formulation and is not recommended for use in a nebuliser or mechanical ventilator, GlaxoSmithKline has said. Its advice is backed by the Commission on Human Medicines.

  • Zanamivir as effective as oseltamivir at preventing flu symptoms

    5 AUG 2009 16:37

    Zanamivir and oseltamivir administered over an extended period appear to be equally effective at preventing symptomatic influenza among immunocompetent adults, according to a US study published online this week in Annals of Internal Medicine (3 August 2009).

  • Youths with type 2 diabetes benefit from dual therapy

    10 JUL 2012 15:34

    Combination therapy, with metformin plus a glitazone, achieves better glycaemic control than metformin alone in children and adolescents with type 2 diabetes (New England Journal of Medicine 2012;366:2247).  

  • You can’t choose your ancestors Subscription

    26 APR 2008 12:54

    Research at the University of Louisville in Kentucky by Joanna Rowe has found that blue-eyed students perform better academically than brown-eyed individuals. They plan better, study more effectively and produce better examination results. Brown-eyed people have better reaction times in trials and so are more likely to be successful football or tennis players.

  • Sylvie Briand, director of pandemic and epidemic diseases at the World Health Organization

    Yellow fever vaccine shortages could be on the cards, warns WHO Subscription

    12 MAY 2016 13:28

    The World Health Organization has warned that there may be a shortage of yellow fever vaccine if there are any new outbreaks of the viral haemorrhagic disease this year. 

  • Yellow fever booster not needed, says WHO Subscription

    20 MAY 2013 7:09

    A single dose of yellow fever vaccine is enough to protect against infection for life, according to updated advice from the World Health Organization. The WHO’s Strategic Advisory Group of Experts (SAGE) on Immunisation examined current evidence and concluded that the yellow fever booster dose, given ten years after the initial vaccination, is not necessary.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.